Product Images Ebglyss
View Photos of Packaging, Labels & Appearance
- Figure - ebglyss ai ifu 1 v1
- Figure - ebglyss ai ifu 2 v1
- Figure - ebglyss ai ifu 3 v1
- Figure - ebglyss ai ifu 4 v1
- Figure - ebglyss ai ifu 5 v1
- Figure - ebglyss ai ifu 6 v1
- Figure - ebglyss ai ifu 7 v1
- Figure - ebglyss ai ifu 8 v1
- Figure - ebglyss ai ifu 9 v1
- Figure - ebglyss ai lock
- Figure - ebglyss ai unlock
- Figure - ebglyss ifu inj sites 1 v1
- Figure - ebglyss ifu inj sites 2 v1
- Carton Image Placeholder - ebglyss pen carton 084 00
- Carton Image Placeholder - ebglyss pfs carton 9996 02
- Figure - ebglyss pfs ifu 1 v1
- Figure - ebglyss pfs ifu 10 v1
- Figure - ebglyss pfs ifu 2 v1
- Figure - ebglyss pfs ifu 3 v1
- Figure - ebglyss pfs ifu 4 v1
- Figure - ebglyss pfs ifu 5 v1
- Figure - ebglyss pfs ifu 6 v1
- Figure - ebglyss pfs ifu 7 v1
- Figure - ebglyss pfs ifu 8 v1
- Figure - ebglyss pfs ifu 9 v1
- Figure 1 - ebglyss uspi 1 v1
- Figure 2 - ebglyss uspi 2 v1
- Figure - qr v1
Product Label Images
The following 28 images provide visual information about the product associated with Ebglyss NDC 0002-7797 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - ebglyss ai ifu 1 v1
Figure - ebglyss ai ifu 2 v1
This text provides information about a medical device or product with purple injection button, lockring, needle end, lock or unlock symbols, clear base, and gray base cap. The text seems to describe components of a medical syringe or needle.*
Figure - ebglyss ai ifu 3 v1
Figure - ebglyss ai ifu 4 v1
Figure - ebglyss ai ifu 5 v1
Figure - ebglyss ai ifu 6 v1
Figure - ebglyss ai ifu 7 v1
Figure - ebglyss ai ifu 8 v1
Figure - ebglyss ai ifu 9 v1
Figure - ebglyss ai lock
Figure - ebglyss ai unlock
Figure - ebglyss ifu inj sites 1 v1
Figure - ebglyss ifu inj sites 2 v1
Carton Image Placeholder - ebglyss pen carton 084 00
Carton Image Placeholder - ebglyss pfs carton 9996 02
This is a description of a medication named Ebglys (tebrikizumab-lbkz) available in a single-dose prefilled syringe for subcutaneous injection. The dosage provided is 250 mg/2 mL (125 mg/mL). The pharmacy label shows instructions for use.*
Figure - ebglyss pfs ifu 1 v1
Figure - ebglyss pfs ifu 10 v1
Figure - ebglyss pfs ifu 2 v1
This text provides a description of the parts of a syringe that should be checked before use. It includes information on the plunger rod, finger grips, syringe label and expiration date, viewing window, syringe body, and needle cap. Additionally, it mentions the needle after removing the needle cap.*
Figure - ebglyss pfs ifu 3 v1
This is a list of medical supplies: Plunger Rod, Used Syringe with Label & Expiration Date, Used Needle, Activated Needle Shield.*
Figure - ebglyss pfs ifu 4 v1
Figure - ebglyss pfs ifu 5 v1
This description indicates that the item being discussed has a viewing window, likely for monitoring content or information. It also mentions a label with an expiration date, which could be useful for tracking the item's validity or shelf life.*
Figure - ebglyss pfs ifu 6 v1
Figure - ebglyss pfs ifu 7 v1
Figure - ebglyss pfs ifu 8 v1
Figure - ebglyss pfs ifu 9 v1
Figure 1 - ebglyss uspi 1 v1
This is a tabulated data showing the proportion of subjects in two studies: ADvocate 1 and ADvocate 2, comparing the use of EBGLYSS 250mg Q2W versus Placebo. In ADvocate 1, there were 283 subjects in the EBGLYSS group and 141 subjects in the Placebo group. In ADvocate 2, there were 281 subjects in the EBGLYSS group and 146 subjects in the Placebo group. The data is presented as a percentage table.*
Figure 2 - ebglyss uspi 2 v1
This text provides information on the proportion of subjects participating in "ADvocate 1" and "ADvocate 2" studies, comparing the use of EBGLYSS 250mg Q2W to a placebo. The data includes the number of subjects in each group and the percentage for each treatment group.*
Figure - qr v1
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
